InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,112.00
(
-0.03%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
85.09
(
0.04%
)
Bitcoin
58,226.60
(
0.81%
)
Post# of 12142
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

doc2016

Send PM Follow Ignore
Followers 2
Posts 5393
Boards Moderated 0
Alias Born 03/21/2021

doc2016

Re: None

Sunday, 02/18/2024 11:01:19 AM

Sunday, February 18, 2024 11:01:19 AM

Post# of 12142
Bispecific Antibodies (BsAbs):
BsAbs are an exciting class of immunotherapy agents.
They can bind to two different antigens simultaneously, enhancing the immune system’s response.
In cancer treatment, BsAbs direct T cells’ cytotoxic activity against cancer cells.
Notably, Inovio’s DNA-encoded bispecific T-cell engagers (dBiTEs) show transformative potential
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up